Shree Ganesh Remedies Ltd
BSE:540737
Shree Ganesh Remedies Ltd
BSE:540737
Price:
507.2
INR
2.14%
Market Closed
Market Cap:
₹6.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shree Ganesh Remedies Ltd
BSE:540737
|
IN |
|
Centamin PLC
LSE:CEY
|
JE |
|
Smith-Midland Corp
NASDAQ:SMID
|
US |
|
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
|
CN |
|
Asia Tele-Net and Technology Corporation Ltd
HKEX:679
|
HK |
Income Statement
Earnings Waterfall
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd
Income Statement
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd
Currency: INR
| Mar-2019 | Sep-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||
| Interest Expense |
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
353
N/A
|
497
+41%
|
584
+18%
|
729
+25%
|
521
-29%
|
654
+25%
|
491
-25%
|
528
+8%
|
582
+10%
|
661
+14%
|
713
+8%
|
763
+7%
|
806
+6%
|
815
+1%
|
902
+11%
|
993
+10%
|
1 115
+12%
|
1 174
+5%
|
1 259
+7%
|
1 240
-2%
|
1 229
-1%
|
1 220
-1%
|
1 086
-11%
|
1 085
0%
|
1 065
-2%
|
1 005
-6%
|
|
| Gross Profit | |||||||||||||||||||||||||||
| Cost of Revenue |
(185)
|
(291)
|
(356)
|
(427)
|
(257)
|
(321)
|
(220)
|
(229)
|
(279)
|
(324)
|
(370)
|
(399)
|
(417)
|
(429)
|
(471)
|
(521)
|
(594)
|
(598)
|
(649)
|
(519)
|
(472)
|
(431)
|
(441)
|
(362)
|
(356)
|
(335)
|
|
| Gross Profit |
168
N/A
|
206
+23%
|
228
+11%
|
303
+33%
|
264
-13%
|
333
+26%
|
271
-19%
|
299
+10%
|
304
+2%
|
337
+11%
|
343
+2%
|
364
+6%
|
389
+7%
|
386
-1%
|
431
+12%
|
472
+10%
|
521
+10%
|
576
+11%
|
610
+6%
|
720
+18%
|
757
+5%
|
789
+4%
|
645
-18%
|
723
+12%
|
709
-2%
|
670
-5%
|
|
| Operating Income | |||||||||||||||||||||||||||
| Operating Expenses |
(91)
|
(109)
|
(141)
|
(189)
|
(167)
|
(206)
|
(161)
|
(172)
|
(178)
|
(193)
|
(197)
|
(207)
|
(222)
|
(223)
|
(235)
|
(253)
|
(268)
|
(304)
|
(253)
|
(361)
|
(387)
|
(410)
|
(349)
|
(439)
|
(443)
|
(436)
|
|
| Selling, General & Administrative |
(21)
|
(25)
|
(33)
|
(48)
|
(44)
|
(55)
|
(38)
|
(41)
|
(42)
|
(43)
|
(47)
|
(51)
|
(54)
|
(57)
|
(59)
|
(61)
|
(67)
|
(71)
|
(190)
|
(91)
|
(96)
|
(103)
|
(249)
|
(105)
|
(110)
|
(112)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(10)
|
(16)
|
(22)
|
(28)
|
(24)
|
(26)
|
(27)
|
(29)
|
(32)
|
(40)
|
(33)
|
(33)
|
(33)
|
(33)
|
(37)
|
(39)
|
(44)
|
(53)
|
(61)
|
(71)
|
(81)
|
(89)
|
(96)
|
(100)
|
(101)
|
(101)
|
|
| Other Operating Expenses |
(60)
|
(68)
|
(86)
|
(113)
|
(98)
|
(125)
|
(96)
|
(102)
|
(104)
|
(110)
|
(116)
|
(122)
|
(135)
|
(132)
|
(140)
|
(153)
|
(157)
|
(180)
|
(2)
|
(200)
|
(211)
|
(219)
|
(1)
|
(234)
|
(232)
|
(223)
|
|
| Operating Income |
77
N/A
|
98
+27%
|
87
-11%
|
113
+30%
|
97
-14%
|
127
+30%
|
109
-14%
|
127
+16%
|
126
-1%
|
144
+15%
|
146
+1%
|
158
+8%
|
167
+6%
|
163
-2%
|
195
+20%
|
219
+12%
|
253
+16%
|
272
+8%
|
357
+31%
|
359
+1%
|
370
+3%
|
378
+2%
|
296
-22%
|
284
-4%
|
266
-7%
|
234
-12%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(2)
|
(1)
|
(6)
|
(5)
|
(5)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(1)
|
(1)
|
(0)
|
1
|
(1)
|
(1)
|
19
|
(9)
|
(13)
|
(17)
|
5
|
(27)
|
(33)
|
(37)
|
|
| Gain/Loss on Disposition of Assets |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
10
|
20
|
41
|
48
|
36
|
41
|
20
|
23
|
23
|
26
|
35
|
31
|
34
|
39
|
31
|
32
|
33
|
30
|
6
|
31
|
24
|
20
|
11
|
38
|
43
|
43
|
|
| Pre-Tax Income |
87
N/A
|
116
+34%
|
127
+10%
|
156
+23%
|
128
-18%
|
163
+27%
|
129
-20%
|
148
+14%
|
147
-1%
|
169
+15%
|
180
+7%
|
186
+3%
|
200
+7%
|
201
+1%
|
226
+12%
|
252
+11%
|
285
+13%
|
301
+6%
|
382
+27%
|
380
0%
|
380
+0%
|
382
+0%
|
313
-18%
|
295
-6%
|
276
-7%
|
241
-13%
|
|
| Net Income | |||||||||||||||||||||||||||
| Tax Provision |
(24)
|
(30)
|
(31)
|
(35)
|
(28)
|
(35)
|
(32)
|
(36)
|
(35)
|
(43)
|
(46)
|
(47)
|
(52)
|
(51)
|
(56)
|
(63)
|
(70)
|
(82)
|
(101)
|
(100)
|
(102)
|
(97)
|
(82)
|
(77)
|
(72)
|
(60)
|
|
| Income from Continuing Operations |
62
|
86
|
96
|
121
|
100
|
128
|
98
|
112
|
112
|
126
|
134
|
139
|
148
|
150
|
170
|
189
|
215
|
220
|
281
|
280
|
278
|
285
|
231
|
219
|
204
|
181
|
|
| Net Income (Common) |
62
N/A
|
86
+38%
|
96
+12%
|
121
+26%
|
100
-17%
|
128
+28%
|
98
-24%
|
112
+15%
|
112
-1%
|
126
+13%
|
134
+6%
|
139
+4%
|
148
+7%
|
150
+1%
|
170
+14%
|
189
+11%
|
215
+14%
|
220
+2%
|
281
+28%
|
280
0%
|
278
-1%
|
285
+2%
|
231
-19%
|
219
-5%
|
204
-7%
|
181
-11%
|
|
| EPS (Diluted) |
6.23
N/A
|
8.57
+38%
|
7.64
-11%
|
12.11
+59%
|
10.03
-17%
|
12.8
+28%
|
7.75
-39%
|
11.24
+45%
|
11.16
-1%
|
10.48
-6%
|
10.64
+2%
|
11.07
+4%
|
11.79
+7%
|
11.89
+1%
|
13.86
+17%
|
15.35
+11%
|
17.46
+14%
|
17.57
+1%
|
22.34
+27%
|
21.79
-2%
|
21.6
-1%
|
22.15
+3%
|
17.96
-19%
|
17
-5%
|
15.89
-7%
|
14.08
-11%
|
|
Switch to:
Switch to:
See Also
Discover More
